Profile data is unavailable for this security.
About the company
Kopran Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management, gastroenterology, and respiratory. It has a portfolio, producing over 100 dosage forms. These include tablets, capsules, dry powder, suspension and injectables. Its subsidiary, Kopran Research Laboratories Ltd, manufactures a range of APIs, including Atenolol and Sterile Carbapenems.
- Revenue in INR (TTM)6.20bn
- Net income in INR165.43m
- Incorporated1958
- Employees1.02k
- LocationKopran LtdParijat House1076, Dr. E. Moses Road, Worli9917MUMBAI 400018IndiaIND
- Phone+91 2 243661111
- Fax+91 2 224950363
- Websitehttps://www.kopran.com/
Mergers & acquisitions
| Acquired company | KOPRAN:NSI since announced | Transaction value |
|---|---|---|
| Kopran Laboratories Ltd | -29.73% | 23.82m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amanta Healthcare Ltd | -100.00bn | -100.00bn | 3.90bn | 506.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.01 | -- | 189.02 | -- | -- | -- |
| Haleos Labs Ltd | 3.48bn | 198.49m | 3.93bn | 592.00 | 19.79 | -- | 10.80 | 1.13 | 65.66 | 65.66 | 1,150.43 | -- | -- | -- | -- | 5,874,455.00 | -- | 4.26 | -- | 7.05 | 37.48 | 32.35 | 6.02 | 4.76 | -- | 4.44 | -- | 2.85 | 12.67 | 5.74 | 121.15 | 14.58 | -8.05 | -- |
| Medicamen Biotech Ltd | 1.67bn | 83.18m | 4.03bn | 376.00 | 44.04 | -- | 30.62 | 2.42 | 6.75 | 6.75 | 126.58 | -- | -- | -- | -- | 4,434,471.00 | -- | 4.69 | -- | 6.63 | 50.02 | 38.01 | 4.33 | 8.13 | -- | 1.75 | -- | 10.57 | -9.35 | 5.31 | -34.97 | -11.77 | -35.60 | 14.87 |
| Shri Ahimsa Naturals Ltd | 1.16bn | 266.73m | 5.41bn | -- | 15.77 | 3.19 | 18.98 | 4.68 | 14.65 | 14.65 | 61.23 | 72.37 | 0.7957 | 1.80 | 4.75 | -- | 18.36 | 25.55 | 19.42 | 31.51 | 48.63 | 53.50 | 23.07 | 25.19 | 12.68 | -- | 0.00 | -- | 22.86 | 34.75 | 17.31 | 78.70 | 53.34 | -- |
| Kilitch Drugs (India) Ltd | 2.07bn | 264.30m | 5.59bn | 187.00 | 20.17 | -- | 20.08 | 2.70 | 15.87 | 15.87 | 123.46 | -- | -- | -- | -- | 11,074,770.00 | -- | 5.16 | -- | 7.38 | 35.29 | 35.37 | 12.18 | 8.41 | -- | 4.54 | -- | 0.00 | 28.47 | 30.05 | 82.86 | 99.64 | 34.88 | -- |
| Anlon Healthcare Ltd | 1.70bn | 346.64m | 5.90bn | 101.00 | 15.06 | -- | 16.07 | 3.47 | 7.37 | 7.37 | 37.66 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 38.31 | -- | 20.39 | -- | -- | 11.05 | -- | -- | 80.65 | -- | 112.46 | -- | -- | -- |
| Kopran Ltd | 6.20bn | 165.43m | 6.00bn | 1.02k | 36.38 | -- | 17.97 | 0.9673 | 3.41 | 3.41 | 128.28 | -- | -- | -- | -- | 6,052,426.00 | -- | 7.85 | -- | 11.25 | 34.20 | 32.04 | 2.67 | 8.66 | -- | 2.39 | -- | 29.60 | 2.44 | 11.86 | -24.34 | 12.90 | 33.20 | -- |
| Fabtech Technologies Ltd | 3.87bn | 313.94m | 6.32bn | -- | 14.38 | -- | 17.53 | 1.63 | 9.88 | 9.88 | 115.92 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 44.01 | -- | 8.11 | -- | -- | -- | -- | -- | 44.46 | -- | 70.67 | -- | -- | -- |
| Remus Pharmaceuticals Ltd | 7.48bn | 325.59m | 7.25bn | 68.00 | 19.77 | 2.36 | 16.47 | 0.9691 | 31.11 | 31.11 | 701.20 | 260.51 | 1.89 | 9.07 | 7.21 | 109,981,700.00 | 10.44 | 14.37 | 18.44 | 28.60 | 13.01 | 19.39 | 5.51 | 8.39 | 1.07 | 35.59 | 0.0452 | 3.59 | 191.93 | 120.44 | 34.98 | 104.56 | 48.07 | -- |
| Themis Medicare Ltd | 3.37bn | -174.06m | 7.27bn | 1.76k | -- | -- | -- | 2.15 | -1.89 | -1.89 | 36.52 | -- | -- | -- | -- | 1,917,083.00 | -- | 10.17 | -- | 14.38 | 62.56 | 60.61 | -5.16 | 13.52 | -- | -3.71 | -- | 9.36 | 6.22 | 15.00 | -31.46 | 3.78 | 21.58 | 23.36 |
| Sigachi Industries Ltd | 4.84bn | -762.02m | 7.40bn | 1.10k | -- | -- | -- | 1.53 | -1.97 | -1.97 | 14.66 | -- | -- | -- | -- | 4,421,398.00 | -- | 12.29 | -- | 16.21 | 50.57 | 51.93 | -15.34 | 14.80 | -- | 3.73 | -- | 4.23 | 22.38 | 28.55 | 21.66 | 27.91 | 48.87 | -- |
| Anuh Pharma Ltd | 7.68bn | 418.22m | 7.75bn | 295.00 | 18.53 | -- | 14.64 | 1.01 | 4.17 | 4.17 | 76.65 | -- | -- | -- | -- | 26,023,040.00 | -- | 10.41 | -- | 17.00 | 22.25 | 23.95 | 5.45 | 7.35 | -- | 116.27 | -- | 26.59 | 2.24 | 16.60 | -21.16 | 27.05 | -10.78 | 16.89 |
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 60.31k | 0.13% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 46.65k | 0.10% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 20.99k | 0.04% |
| DFA Australia Ltd.as of 31 Jan 2026 | 5.74k | 0.01% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Jan 2026 | 848.00 | 0.00% |
| Bandhan AMC Ltd.as of 31 Jan 2026 | 333.00 | 0.00% |
